Where does KCI USA, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), KCI USA, Inc. ranks #10,368 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does KCI USA, Inc. hold?

KCI USA, Inc. holds 30 US utility patents granted between 2015 and 2024, spanning 11 technology areas.

What is KCI USA, Inc.'s Innovation Score?

KCI USA, Inc. has an Innovation Score of 35.1 out of 100 (top 50% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is KCI USA, Inc.'s patent grant rate increasing or decreasing?

KCI USA, Inc.'s recent grant velocity is -70% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for KCI USA, Inc.'s patents?

KCI USA, Inc.'s patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the KCI USA, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

KCI USA, Inc.

Q: What technology areas does KCI USA, Inc. focus on?

KCI USA, Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 22 patents, ranking #296 of 3,082 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 30 granted patents across 11 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, KCI ranks #10,368 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 11 technology areas.

#10,368
of 49,997 US assignees by volume: Top 50%
by Innovation Score (35.1/100): 17.3
avg claims per patent: -70%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10368 · US Corporation #10,368 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 30 grants
UPPER-Q #10,368/49,997
PHOTO-FINISH Jabil Optics Germany
CPC-FOCUS A61F · 11 areas
INNOV-THIN 35.1/100
CLAIMS-RICH 17.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -70% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Jabil Optics Germany GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How KCI’s 35.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.9 pts (34%) Velocity 1.1 pts (3%) Breadth 11.7 pts (33%) Claim depth 10.4 pts (30%)

Qualcomm Incorporated · highest

85
Advanced Access · near

35
KCI USA · this assignee

35
Phazr · near

35
SunASIC · near

35
Usablenet · near

35
3D Lighting… · lowest

7

What this shows KCI's Innovation Score is 35.1/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for KCI?

Each dot is one of KCI’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). KCI’s own 17.3 claims/patent is ABOVE the 11.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

KCI vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where KCI's grants concentrate

KCI USA, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 73.3% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (7 grants) versus a trough of 2 in 2016. By volume, KCI sits between Jarllytec Co., Ltd. and Kount Inc..

KCI's three-year grant acceleration

KCI USA, Inc. shows 2 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Jarllytec

30
Jetoptera

30
Jabil Optics Germ…

30
John Nicholas and…

30
Kendrion (Villing…

30
Knipex-werk C Gus…

30
Knu-industry Coop…

30
Kount

30
KCI USA ◀

30

What this shows KCI holds 30 patents at rank #10,366, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near KCI

By rank, the assignees closest to #10,366 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in KCI's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for KCI, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), KCI ranks #296 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Phazr, Inc. 35 Advanced Access Technologies LLC 35 SunASIC Technologies, Inc. 35 Usablenet Inc. 35

KCI's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 50% higher than 50% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

KCI USA, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	10.0%
2016	2	6.7%
2017	7	23.3%
2018	4	13.3%
2019	7	23.3%
2020	3	10.0%
2021	2	6.7%
2024	2	6.7%

Which technologies does KCI USA, Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 22

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 16

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

Y10T - Technical Subjects Covered BY Former US Classification 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 3

C09J - ADHESIVES; Non-mechanical Aspects OF Adhesive Processes IN GENERAL; Adhesive Processes NOT Provided FOR ELSEWHERE; USE OF Materials AS Adhesives 2

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 2

C01B - Non-metallic ELEMENTS; Compounds THEREOF; ; Metalloids OR Compounds Thereof NOT Covered BY Subclass C01c 1

C08L - Compositions OF Macromolecular Compounds 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

KCI USA, Inc.'s patent record in context - here's where to go next.

KCI USA, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 73.3% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #10,368 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare KCI USA, Inc. against Jarllytec Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.